August 21, 2025 — Moderna, Inc. (NASDAQ: MRNA) today announced its participation in two upcoming investor conferences:
- Morgan Stanley’s 23rd Annual Global Healthcare Conference on Monday, September 8th at 10:00 AM ET
- Bernstein Insights: Healthcare Leaders and Disruptors on Thursday, September 25th at 10:30 AM ET
Live webcasts of these presentations will be available under the “Events and Presentations” section in the Investors area of Moderna’s website at investors.modernatx.com. Replays will be archived for at least 30 days after each presentation.
About Moderna
Moderna is a pioneer in mRNA medicine, transforming how medicines are made and disease prevention is approached.
With its innovative mRNA platform, the company has developed groundbreaking therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, and autoimmune diseases.
Moderna continues to push the boundaries of medical science with speed and efficiency, most notably with one of the earliest and most effective COVID-19 vaccines.
